Pluri Subsidiary Puri Biotech Secures Patent Covering 3D Immune Cell Expansion Tech
Benzinga Newsdesk 8 months ago
News
The China National Intellectual Property Administration (CNIPA) has granted Pluri Biotech Ltd., a wholly owned subsidiary of Pluri, a patent covering its proprietary 3D immune cell expansion and activation
The China National Intellectual Property Administration (CNIPA) has granted Pluri Biotech Ltd., a wholly owned subsidiary of Pluri, a patent covering its proprietary 3D immune cell expansion and activation technology.